// App-Quantinova.ai

: Inecalcitol Enhances Daratumumab-Induced Antibody-Dependent Cell Cytotoxicity Towards Multiple Myeloma and Acute Myeloid Leukemia Cell Lines

Researchers

Presenter

  • Enguerran Mouly

Principal Investigators

  • Cecile Planquette

  • Emilie Rousseau

  • Remi Delansorne

Medical Centers

  • Hybrigenics, Paris, France.

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • T-cell acute lymphoblastic leukemia

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • cholecalciferol

  • daratumumab Intravenous

  • inecalcitol

  • Ergocalciferol

  • Sparsentan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved